Predictive Biomarkers and Personalized Medicine Evaluation of Circulating Tumor Cells and Circulating Tumor DNA inNon – SmallCell LungCancer : AssociationwithClinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
暂无分享,去创建一个
G. Hampton | L. Amler | R. Hicks | M. Lackner | B. Fine | E. Punnoose | B. Hughes | R. Raja | A. Pirzkall | Weiqun Liu | S. Atwal